Detecting harmful free radicals using advanced nanodiamond sensors
Nanodiamond Quantum Sensors for Free Radical Detection
This study is exploring a new way to measure harmful molecules in your blood that can affect your health, using special tiny diamonds, which could help doctors find better ways to diagnose and treat diseases related to these molecules.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Adamas Nanotechnologies, INC. NIH-funded |
| Lab location | 1 site (Raleigh, UNITED STATES) |
| Project ID | NIH-11007965 on NIH RePORTER |
What this research studies
This research focuses on developing a novel quantum sensing technology that can accurately measure reactive oxygen species (ROS) in biological fluids like whole blood. By utilizing nanodiamonds with unique quantum properties, the sensors aim to provide sensitive and rapid detection of free radicals, which play a crucial role in various diseases. The goal is to enhance our understanding of how these species contribute to health and disease, potentially leading to new diagnostic tools and treatment options. Patients may benefit from improved diagnostics and therapies that target ROS-related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions linked to oxidative stress or free radical damage.
Not a fit: Patients with conditions unrelated to oxidative stress or free radical activity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatments for diseases associated with free radical misregulation.
How similar studies have performed: Other research has shown promise in using quantum sensors for biological applications, indicating potential success for this novel approach.
Where this research is happening
Raleigh, UNITED STATES
- Adamas Nanotechnologies, INC. — Raleigh, United States (Active)
Researchers
- Principal investigator: Torelli, Marco — Adamas Nanotechnologies, INC.
- Study coordinator: Torelli, Marco
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.